LIVZON PHARMAC. GRP H YC1 (LP6) — Free Cash Flow Generation Index
LIVZON PHARMAC. GRP H YC1 (LP6) has a Free Cash Flow Generation Index of 0.82x as of December 2025. Free cash flow of €2.57 Billion represents 1% of operating cash flow (€3.15 Billion). Explore reinvestment intensity of LIVZON PHARMAC. GRP H YC1 to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
LIVZON PHARMAC. GRP H YC1 Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for LIVZON PHARMAC. GRP H YC1 across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of LIVZON PHARMAC. GRP H YC1.
Annual Free Cash Flow Generation for LIVZON PHARMAC. GRP H YC1 (2021–2025)
Year-by-year Free Cash Flow Generation Index for LIVZON PHARMAC. GRP H YC1. Check LIVZON PHARMAC. GRP H YC1 (LP6) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | €2.57 Billion | €3.15 Billion | €574.14 Million | ▲ +1.1% |
| 2024 | 0.81x | €2.41 Billion | €2.98 Billion | €570.16 Million | ▲ +8.2% |
| 2023 | 0.75x | €2.43 Billion | €3.25 Billion | €820.45 Million | ▲ +13.1% |
| 2022 | 0.66x | €1.83 Billion | €2.77 Billion | €940.15 Million | ▲ +111.9% |
| 2021 | 0.31x | €593.23 Million | €1.90 Billion | €1.31 Billion | — |